Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-15

FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) from Insight Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MONISTAT 3 3 DAY (MICONAZOLE NITRATE)

Snippet

SUPPL AP for MONISTAT 3 3 DAY (MICONAZOLE NITRATE)